![]() |
Volumn 39, Issue 8, 2005, Pages 745-746
|
Which combination should be preferred in the management of children with chronic hepatitis B infection? [4]
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
LAMIVUDINE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG SAFETY;
HEPATITIS B;
HUMAN;
LETTER;
MONOTHERAPY;
PEDIATRICS;
PRIORITY JOURNAL;
VIROLOGY;
ANTIVIRAL AGENTS;
CHILD;
DECISION MAKING;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
LAMIVUDINE;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT OUTCOME;
|
EID: 23844531184
PISSN: 01920790
EISSN: None
Source Type: Journal
DOI: 10.1097/01.mcg.0000173934.46654.1e Document Type: Letter |
Times cited : (3)
|
References (6)
|